Adjuvant Capital GP, L.P. - Insider Non-Derivative Transactions at AN2 Therapeutics, Inc. (ANTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 13, 2023, Adjuvant Capital GP, L.P.'s relationship to AN2 Therapeutics, Inc. (ANTX) is TenPercentOwner, and currently has 2,177,547 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ANTX insiders.
Data Source: SEC.
Adjuvant Capital GP, L.P. - Insider Non-Derivative Transactions at ANTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 14, 2023 | Sell -- (Common Stock) | 64 | 16 | 411893 |
| Sep 14, 2023 | Sell -- (Common Stock) | 336 | 16 | 2177547 |